Clinical Trials Directory

Trials / Completed

CompletedNCT06897306

Gastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study

Surgery Significantly Improves the Prognosis of Locally Advanced Gastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
317 (actual)
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

This study aims to collect data of patients with Gastric-type Endocervical Adenocarcinoma from the SEER database, analyze the related prognostic factors and treatment patterns of Gastric-type Endocervical Adenocarcinoma, and explore the impact of surgical treatment on the prognosis of locally advanced Gastric-type Endocervical Adenocarcinoma.

Detailed description

This study aims to collect data of patients with Gastric - type Endocervical Adenocarcinoma from the SEER database, analyze the related prognostic factors and treatment patterns of patients with Gastric - type Endocervical Adenocarcinoma, and explore the impact of surgical treatment on the prognosis of locally advanced Gastric - type Endocervical Adenocarcinoma. Study subjects: Patients diagnosed with Gastric - type Endocervical Adenocarcinoma were identified using the SEER database and SEER\*Stat 8.4.2 software. The search scope was the "SEER Research Plus Data, 17 Registries, Nov 2021 sub (2000 - 2019)" database, and the screening criteria included "Site and Morphology, Analytic Behavior Recode = Malignant" and "Site and Morphology, ICD - O - 3 / WHO 2008 Recode Site = Cervix". Patients with cervical Gastric - type Endocervical Adenocarcinoma were selected from the database. Outcome measures: Overall survival (OS): The time from diagnosis to death of the patient.

Conditions

Interventions

TypeNameDescription
PROCEDUREsurgeryThe patient underwent surgery.

Timeline

Start date
2024-10-01
Primary completion
2024-11-01
Completion
2025-01-20
First posted
2025-03-26
Last updated
2025-03-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06897306. Inclusion in this directory is not an endorsement.